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Attoliter protein nanogels from droplet nanofluidics 
for intracellular delivery
Zenon Toprakcioglu1*, Pavan Kumar Challa1*, David B. Morse1,2, Tuomas Knowles1,3†
Microscale hydrogels consisting of macromolecular networks in aqueous continuous phases have received 
increasing attention because of their potential use in tissue engineering, cell encapsulation and for the storage 
and release of cargo molecules. However, for applications targeting intracellular delivery, their micrometer-scale 
size is unsuitable for effective cellular uptake. Nanoscale analogs of such materials are thus required for this key 
area. Here, we describe a microfluidics/nanofluidics-based strategy for generating monodisperse nanosized water-
in-oil emulsions with controllable sizes ranging from 2500 ± 110 nm down to 51 ± 6 nm. We demonstrate that these 
nanoemulsions can act as templates to form protein nanogels stabilized by supramolecular fibrils from three 
different proteins. We further show that these nanoparticles have the ability to penetrate mammalian cell mem-
branes and deliver intracellular cargo. Due to their biocompatibility and lack of toxicity, natural protein-based 
nanoparticles present advantageous characteristics as vehicles for cargo molecules in the context of pharmaceutical 
and biomedical applications.
INTRODUCTION
Addressing the challenge of cellular permeability for controlled de­
livery applications requires the systematic formation of suitable nano­
particles. Because of their small size, such particles are ideal, indeed 
essential, for targeted drug delivery applications (1–3) and, further­
more, have been used in pharmaceutical, cosmetic, food, and material­ 
based industries (4–7). Currently, a variety of methods for generating 
nanoscale particles are available, such as ultrasonic emulsification 
techniques, spray drying, phase separation/coacervation methods, 
solvent extraction, or even bulk emulsion and polymerization tech­
niques (8). However, control over size and monodispersity, which 
are essential in regulating molecular release, remains problematic. 
A technique that can reproducibly generate highly monodisperse 
particles on larger scales is microfluidics. Droplet microfluidics in 
particular, where two immiscible phases intersect resulting in the 
formation of micrometer­sized droplets (9), has been used, through 
compartmentalization and parallelization (9–11), for carrying out 
polymerase chain reactions (12) and cell­based (13) and DNA binding 
assays (14), and for protein nanofibrillar aggregation studies (15, 16). 
Conventional polydimethylsiloxane (PDMS)–based microfluidics has 
been used to generate monodisperse water­in­oil microemulsions 
with extremely high controllability. However, for applications in­
volving drug/gene delivery, these micrometer­sized emulsions are 
far too large, as effective particle transfer through the cell membrane 
typically occurs if the drug carrier is less than 1 m. Currently, it 
remains a challenge to generate monodisperse nanoemulsions using 
conventional microfluidics (17).
Droplet microfluidics has been used for the generation of func­
tional materials such as hydrogels/microcapsules (18, 19) or microgels 
(15, 20–22). By encapsulating polymers and/or proteins within the 
aqueous phase, the propensity of such systems to self­assemble into 
supramolecular structures can be used. These materials may even 
display different and/or beneficial properties when compared to 
bulk studies (23–27). Recently, there has been an increased interest 
in the generation of protein­based microgels as versatile biomaterials 
(15, 20, 21) for various applications including the storage and deliv­
ery of cargo molecules. Because of the high level of monodispersity 
within the sample, release kinetics for drug delivery applications not 
only are reproducible but also, more importantly, can be specifically 
tailored for each individual system. In addition, the use of protein­ 
based materials as opposed to synthetically prepared ones offers ad­
vantages such as biocompatibility, lack of toxicity, immunogenicity 
(28), and natural self­assembly.
To address the issue of controlled generation of nanosized mono­
disperse droplets, we have explored the possibilities offered by 
nanofluidic platforms. We report the generation of water­in­oil 
nanodroplets with low polydispersity using conventional PDMS­
based micro­ and nanofluidics. A two­step soft lithographic process 
is used to integrate micrometer­sized channels with nanosized 
ones. Submicrometer­sized droplets with tunable diameters rang­
ing from 2.5 m down to ∼50 nm were formed from three different 
protein solutions, reconstituted silk fibroin, ­lactoglobulin, and 
lysozyme, which were used as the aqueous phase. Droplets were then 
incubated to promote protein self­assembly resulting in the forma­
tion of a fibrillar network within them. Subsequently, nanoparticle 
characterization was done using electron microscopy and dynamic 
light scattering (DLS). Last, mammalian cell assays revealed that the 
nanogels have the ability to penetrate into cells through the mem­
brane. For potential applications, we find that this facile and versatile 
route of protein nanogel formation is highly suitable for the storage 
and release of drugs that may be delivered to their intended desti­
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of an aqueous phase, consisting of a protein solution, in a continuous 
immiscible oil phase. To generate nanosized droplets, microchannels 
were integrated with nanochannels using a soft lithographic process, 
allowing for a robust nano­to­micro and chip­to­world interface. 
The master used in all experiments was fabricated using two­step 
lithography (Fig. 1A). Structures that were 800 nm wide were formed 
from a chrome mask (Fig. 1B) and aligned with micrometer­sized 
channels fabricated from a film photomask (Fig. 1C) resulting in the 
device shown schematically in Fig. 1A, the junction of which can be 
seen in magnification in Fig. 1D (see Materials and Methods for further 
details on device fabrication). The integration between the micro and 
nano areas of the device is shown in the schematic representation 
in Fig. 2A.
Droplet generation occurs when the phase to be dispersed inter­
sects with an immiscible continuous phase, resulting in a break­off 
of the former into the bulk fluid stream (29). This is schematically 
represented in Fig. 2A, which depicts how monodisperse nanodroplets 
were formed. Typically, droplet size depends on volumetric flow rates 
of both the continuous and dispersed phases, the viscosity of the 
fluids, and the interfacial tension. However, a crucial factor in de­
termining droplet size is channel dimensions at the junction (i.e., 
where the two liquids intersect) and, in particular, the cross­sectional 
area of the rectangular channel. As such, both the width and the 
height of the junction need to be precisely known. To that effect, the 
dimensions of the nanosized channels were characterized. Scanning 
electron microscopy (SEM) was used to determine the width of the 
channels, which was found to be approximately 800 nm (Fig. 1, 
E and F), while atomic force microscopy was used to measure the 
height of the junction. The latter was found to be 400 ±30 nm, as 













Fig. 1. Design and characterization of the nanofluidic device used. (A to D) Design of the microfluidic device used. A two-step lithographic process was used to 
fabricate the device shown in (A). (B) Mask 1: Chrome mask used that enabled the fabrication of the nanochannels. (C) Mask 2: Conventional film photomask is carefully 
aligned with mask 1, resulting in a two-layered master. (D) Schematic design of the T-junction used to generate nanodroplets. (E and F) Scanning electron microscopy 
(SEM) micrographs of the nanodroplet-generating device. (F) Magnified SEM image of the junction. (G) Atomic force microscopy micrograph of the nanochannels shown 
in (F). (H) Corresponding height profile of the junction shown in (G).
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profile, acquired by atomic force microscopy, is shown in Fig. 1H. 
This is in agreement with the theoretical height that should have 
been achieved (∼500 nm) using the spin­coating process described 
in Materials and Methods.
Nanodroplet and nanoparticle formation
Next, we explored the generation of micrometer­ and submicrometer­ 
scale water­in­oil droplets using the nanofluidic device. The flow 
rate of the dispersed phase Qdis was kept constant at 10 l/hour, 
while the continuous phase flow rate Qcont was varied from 10 to 
60 l/hour. Optical micrographs of droplet generation at the junction 
can be seen in fig. S1 and movie S1. Having established the repro­
ducible generation of nanoemulsions on chip, we next explored 
their ability to act as templates for the formation of protein nano­
gels. To this effect, reconstituted silk fibroin was added to the aqueous 






































Fig. 2. Analysis of nanoparticle formation using electron microscopy. (A) Schematic representation of water-in-oil nanodroplet generation and consequent 
de-emulsification resulting in the formation of nanogels. (B) Transmission electron microscopy (TEM) micrograph of silk nanoparticles that have a diameter of ∼190 nm. 
(C to F) SEM micrographs of silk nanoparticles. Particle size is strongly dependent on the flow rates used within the microfluidic channels. For all images, the dispersed 
phase was kept constant at 10 l/hour, while the continuous phase varied from 10 to 60 l/hour. Nanoparticles that were 200 nm in size were obtained when Qcont = 
40 l/hour. (D) Nanoparticles that were 100 nm in size were obtained when Qcont = 50 l/hour. (E) Last, 50-nm-sized nanoparticles could be formed when Qcont = 60 l/hour. 
(F) The concentration of silk used for all the nanodroplet generation was 4 mg/ml. (G and H) Size distribution histograms of the silk nanoparticles corresponding to (E) and 
(F), respectively.
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as the dispersed phase. Following formation, nanodroplets were col­
lected from the outlet, as shown in fig. S2D, and placed on a glass 
coverslip to image (fig. S2, A to C). Conversion of soluble monomer 
protein molecules into nanofibrillar aggregates was initiated through 
incubating the nanoemulsion at 37°C for 24 hours. The droplets were 
then de­emulsified (see Materials and Methods) and re­emulsified 
into an aqueous phase.
Figure 2 (B to F) shows transmission electron microscopy (TEM) 
and SEM micrographs of silk fibroin nanospheres obtained using 
this approach. The samples were obtained using a silk fibroin con­
centration of 4 mg/ml, while different­sized nanodroplets were gen­
erated by varying the ratio of the flow rates Qcont/Qdis. The SEM 
images show monodisperse, spherical particles with a smooth surface 
morphology. Qcont/Qdis values of 1, 1.5, and 2 were used to obtain 
particle sizes of 1500, 900, and 500 nm, SEM micrographs of which 
are shown in fig. S3 (A to C, respectively). Furthermore, when the 
ratio Qcont/Qdis was 4, nanodroplets as small as 200 nm were formed. 
TEM was used to characterize these nanoparticles, and it was found 
that the diameter measured through TEM agrees with DLS mea­
surements (fig. S4A), implying that there is minimal shrinkage of 
the nanoparticles upon drying, which has been shown to be the case 
by other synthesis methods (29, 30). Further evidence of this can be 
seen from the micrographs in fig. S2 (B and C), where no shrinkage 
is observed following droplet formation.
To synthesize silk nanoparticles that are sufficiently small to 
penetrate cell membranes (typically <200 nm), we further increased 
the continuous phase flow rate while keeping the dispersed phase 
flow rate constant at 10 l/hour. Figure 2 (D to F) shows SEM 
micrographs of the resulting silk nanogels as a function of the dif­
ferent continuous phase flow rates used. Particles ranging from 204 ± 
19 to 51 ± 6 nm could be synthesized by varying the continuous 
phase flow rate from 40 to 60 l/hour. Particle size could be de­
creased by a factor of 2 by slightly increasing the continuous phase 
flow rate (from 50 to 60 l/hour), as can be seen in the SEM micro­
graphs (Fig. 2, E and F) and the corresponding histogram plots 
(Fig. 2, G and H). This suggests that control over emulsion size can 
be precisely achieved even at the submicrometer scale. The histograms 
shown in Fig. 2 (G and H) were obtained by measuring particle 
diameters of the corresponding SEM images and were fitted to a 
Gaussian distribution. The mean diameters () and SD () of the 
samples shown in Fig. 2 (E and F) were 101 ± 8 and 51 ± 6, respec­
tively. The coefficient of variation (which is the ratio of / and gives 
an indication of the dispersion of the distribution) for these samples 
was calculated as 8 and 12%, respectively, demonstrating a fairly 
narrow distribution for both cases.
The high versatility of this approach was further exhibited by 
generating submicrometer droplets using either ­lactoglobulin or 
lysozyme solutions. In both cases, droplet formation was successful, 
and consequently, nanodroplets were incubated at 65°C for 2 days 
to promote protein aggregation. Following the same procedure as 
previously mentioned for silk nanogels, ­lactoglobulin and lyso­
zyme droplets were de­emulsified and placed in an aqueous phase 
before imaging. Figure 3 (A to C) shows (SEM) micrographs of 
­lactoglobulin nanospheres, while lysozyme nanoparticles are shown 
in fig. S4 (B to D). The samples were obtained using a concentration 
of 50 mg/ml for both ­lactoglobulin and lysozyme, and again, nano­
droplet size could be specifically controlled by varying the ratio of 
the flow rates Qcont/Qdis. The SEM images in Fig. 3 (A to C) show 
high monodispersity, while the spherical ­lactoglobulin particles 
exhibit smooth surface morphology just like their silk counterpart. 
Furthermore, nanogel stability over time was investigated. Once 
formed, in the absence of external environmental factors such as 
bacteria or cells, the nanogels should not degrade. It was found that 
the nanoparticles were stable in the oil phase after 3 months at room 
temperature, and we believe that in the oil phase, the nanogels should, 
in theory, be stable even longer. In an aqueous environment, it was 
determined using SEM that after 1 month, the nanogels were still 
stable. However, because of bacterial contamination, we predict that 
nanogel stability will degrade over time, as the bacteria can digest 
the proteins and break the nanoparticles apart.
The relationship between Qcont and the size of the droplets formed 
was further investigated for both protein solutions. This was deter­
mined by keeping Qdis constant at 10 l/hour, while Qcont values 
ranged from 10 to 60 l/hour. Monodisperse nanodroplets were 
formed, and their sizes were measured by analyzing the corresponding 
SEM micrographs. As expected, a decrease of Qcont leads to increasing 
droplet size, which can be seen in Fig. 3D. Our data further suggest 
not only that all three protein solutions exhibit the same asymptotic 
relation between particle diameter and the flow rate ratio (Qcont/Qdis) 
but also that particle diameters can vary by more than one order of 
magnitude (which is the case for silk nanospheres). Hence, in view 
of this asymptotic behavior, for a given device geometry, there is 
a practical lower limit to droplet size. However, if smaller nano­
channels were fabricated, then theoretically particle size could be 
further decreased.
The viscosity of both the continuous and dispersed phase solu­
tions affects the break­off of droplets and plays a role on defining 
droplet size. This is evident in Fig. 3D, where, for the same flow 
rates and continuous phase, different sized droplets were formed when 
the disperse phase was changed. Both lysozyme and ­lactoglobulin 
exhibited similar behavior, while smaller­sized droplets were formed 
from the solution containing silk fibroin. It has been shown that 
the higher the viscosity of the dispersed phase, the smaller the 
resulting droplet diameter (29). This result is in agreement with 
our observations, where, for the same Qcont/Qdis, the higher­viscosity 
silk fibroin solution was used to form 51 ± 6–nm­sized nanogels, 
while droplet diameters of 350± 21 and 550 ± 36 nm were generated 
from the lower­ viscosity ­lactoglobulin and lyszoyme solutions, 
respectively.
Last, to determine whether the nanoparticles produced using 
this droplet­based approach can be used for intracellular applica­
tions, cell studies were conducted. Increasing evidence in the lit­
erature suggests that cellular uptake of nanoscale particles occurs 
predominantly via a phagocytosis mechanism, and it has been pre­
viously reported that nanoparticles can be endocytosed via such a 
pathway (31–33). Ovarian cancer cells (PEO1) were stained with 
CellTracker Violet BMQC Dye (ex = 415 nm and em = 516 nm) 
and cultured. Nanodroplets composed of silk fibroin (4 mg/ml) and 
green fluorescent protein (GFP) (0.1 mg/ml) (which was used as a 
fluorescent marker) were generated and incubated off­chip to pro­
mote protein aggregation. Two different size distributions were 
produced: 200 and 1000 nm. The droplets were then de­emulsified 
(see Materials and Methods) and reimmersed into deionized wa­
ter before being added to the cell culture and left to incubate for 
4 hours. Last, the cells were washed to remove any excess nano­
particles and then imaged using confocal microscopy. Cells are de­
picted in red throughout Fig. 4, while the nanoparticles are shown 
in green.
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Cell controls containing no nanoparticles show very low fluores­
cence signal at an emission wavelength of 510 nm, which is a charac­
teristic peak for GFP (Fig. 4A). However, with the addition of the 
200­nm­sized nanoparticles, green areas that clearly overlap with cells 
can be seen in Fig. 4 (B and C). The 1000­nm­sized nano particles 
were also tested; however, the particle diameter was too large, and 
the cell was not able to uptake these micrometer­sized particles (fig. S4, 
E and F). Last, a three­dimensional (3D) reconstruction of single cells 
was performed to determine whether the nanoparticles just adhere 
to the cell membrane or whether they do, in fact, penetrate the cell. 
The same cell is shown at three different angles (rotated with respect 
to the z axis) in Fig. 4D to better exhibit the fact that the protein 
nanoparticles are indeed within the cell (see movie S2), while in 
Fig. 4E, the same conclusion can be reached for a different cell.
DISCUSSION
The issue of forming monodisperse nanoparticles in the context of 
cellular permeability for delivery applications remains challenging. 
The need for uniformly sized particles lies in the ability to regulate 
molecular release and specifically tailor the rate of cellular perme­
ation for different nanoparticle diameters (1–3). There are currently 
numerous methods for generating nanoscale particles such as spray 
drying or solvent extraction (8); however, systematic control over 
monodispersity and size is difficult to achieve. In this respect, droplet 
microfluidics has gained popularity because of the ease with which 
highly monodisperse water­in­oil microemulsions can be formed (9). 
However, owing to their size, these microparticles are far too large 
to permeate the cellular membrane. Controllable formation of mono­
disperse nanosized water­in­oil droplets in a reproducible manner 
is thus desirable for next­generation delivery strategies, yet remains a 
challenge. Here, we show that by integrating micro­ and nanofluidics 
using soft lithography, a scalable platform for nanoemulsion­ templated 
material synthesis can be developed (Fig. 1). We demonstrate that 
using this approach, control over nanodroplet diameter can be achieved 
by varying the ratio of the continuous to the dispersed phase flow 
rate. In addition, we have shown that when protein monomer is 
added to the dispersed phase, protein self­assembly can be induced 
by incubating the nanodroplets at high temperatures, resulting in 
the formation of protein nanogels. We show that these nanogels can 
be formed by a range of different proteins, while nanoparticles as 
small as 50 nm with narrow size distributions can be generated 
(Fig. 2, D to H). Furthermore, the nanogels are remarkably robust 
since we did not observe significant droplet shrinkage upon elimi­
nation of the continuous phase, as particle diameters determined by 
SEM agree with DLS measurements. Last, assays with living cells 
revealed that the protein­based nanoparticles have the ability to 
penetrate the membrane into cells and deliver small­molecule cargo 
(Fig. 4). On the other hand, micrometer­sized particles were far too 















Fig. 3. SEM characterization of -lactoglobulin nanoparticles and droplet size dependence on flow rate ratio. (A to C) SEM micrographs of -lactoglobulin 
nanoparticles obtained by varying the continuous oil phase flow rate while keeping the aqueous dispersed phase constant at 10 l/hour. Qcont was 40 and 30 l/hour 
for (A) and for (B) and (C), respectively. (D) Graph showing the dependence of droplet diameter as a function of the ratio of the two flow rates Qcont/Qdis for different 
proteins. For all three cases, the droplet size increases asymptotically as Qcont/Qdis decreases.
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nanogels represent a class of biocompatible and nontoxic materials, 
and in conjunction with the high level of control over their formation, 
they exhibit favorable characteristics as a platform to explore drug 
delivery and related biomedical applications.
MATERIALS AND METHODS
Device fabrication
A two­step photolithographic process was used to fabricate the master 
used for casting PDMS devices. A 500­nm­thick negative photoresist 
(SU­8 2000.5, MicroChem) was spin­coated onto a silicon wafer. 
This, in turn, was soft­baked for 2 min at 95°C. The chrome mask in 
Fig. 1B was then placed onto the wafer, exposed under ultraviolet 
(UV) light to induce polymerization, and then post­baked at 95°C 
for 3 min. A second 25­m­thick layer (SU­8 3025, MicroChem) 
was then spin­coated onto the wafer and soft­baked for 5 min 95°C. 
The second mask (shown in Fig. 1C) was aligned with respect to the 
patterns formed from the first mask. This was, in turn, exposed 
to UV light and post­baked for 15 min at 95°C. Last, to remove 
uncross­linked photoresist, the master was developed in propylene 
glycol methyl ether acetate (Sigma­Aldrich).
A 10:1 ratio of elastomer PDMS to curing agent (SYLGARD 184, 
Dow Corning, Midland, MI) was used to fabricate microfluidic de­
vices. The mixture was cured for 3 hours at 65°C. The hardened PDMS 
was cut and peeled off the master, while holes of 0.75 mm were 
punched on the PDMS. This was then bonded onto a glass slide by treat­
ing with a plasma bonder (Diener Electronic, Ebhausen, Germany).
Droplet formation
The flow rates within the channels were controlled using neMESYS 
syringe pumps (Cetoni, Korbussen, Germany). For water­in­oil 
droplets, protein solution was used as the dispersed phase, while 
fluorinated oil (Fluorinert FC­40, Sigma Aldrich) containing 2% 
w/w fluorosurfactant (RAN Biotechnologies) was used as the con­
tinuous phase. Protein stock solutions of 4, 50, and 50 mg/ml 
were prepared for reconstituted silk fibroin (purification process 
mentioned below), ­lactoglobulin (Sigma­Aldrich), and lysozyme 
(Sigma­Aldrich), respectively. Note that ­lactoglobulin and lyso­
zyme were prepared in a pH 1.6 solution, which was adjusted 
using HCl. In addition, Mikrotron high­speed cameras were used 
for imaging.
Electron microscopy
For SEM, the sample was mounted onto a silicon wafer, and a 5­nm 
platinum layer was then sputter­coated onto it. Images were ob­
tained using a TESCAN MIRA3 FEG­SEM at 5 kV.
For TEM, the sample was mounted onto a carbon grid and 
stained with uranyl acetate. Images were acquired using a Tecnai 
G2 80­ to 200­kV TEM.
Confocal microscopy
A confocal microscope (Leica TCS SP5 X) was used for imaging all 
samples. A diode 405 and an argon laser were used for violet and 
green excitation, respectively. The 3D images were reconstructed 
using ImageJ software.
Fig. 4. Analysis of nanoparticle uptake by ovarian cancer cells. (A to E) Confocal microscopy images of ovarian cancer cells (PEO1), shown in red, with and without 
protein-based nanoparticles, shown in green. (A) Control experiment: Fluorescence microscopy image of the ovarian cancer cells without any protein-based nanoparticles. 
(B and C) Confocal microscopy images for the same cancer cells in the presence of the nanoparticles. (D and E) 3D reconstruction of single cancer cells imaged at different 
angles with respect to the z axis to better show that the nanoparticles have, in fact, penetrated the membrane and are within the cell.
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Nanogel formation and de-emulsification
Nanodroplets were collected and incubated at different tempera­
tures, depending on the protein used. For silk, incubation at room 
temperature for 24 hours induced self­assembly and, consequently, 
formation of nanogels, while ­lactoglobulin and lysozyme were in­
cubated at 65°C. Nanogels were separated from the continuous oil 
phase by the following process: a solution of 20% 1H,1H,2H,2H­ 
perfluoro­octanol (Alfa Aesar) in FC­40 oil was prepared and con­
sequently added to the emulsion. An equal amount of deionized 
water was also added to the emulsion. The samples were next cen­
trifuged at 1000 rpm for 2 min, which resulted in full separation 
of the phases. The supernatant (which contained the nanogels) was 
collected. The washing process was repeated three times.
Silk fibroin preparation and purification
Silk fibroin was obtained from Bombyx mori silk cocoons [Mindsets 
(UK) Limited] by a well­established protocol (28). The cocoons 
were cut into pieces and placed in a beaker containing a solution of 
0.02 M sodium carbonate, which was boiled for 30 min. This ensures 
that the sericin, which is present in the silk fibers, dissolves and 
the insoluble fibroin remains. The fibroin was then removed from 
the beaker, rinsed with cold water three times, and left overnight 
to dry out.
The dried silk fibroin was then dissolved in 9.3 M lithium bromide 
by preparing a 20% (w/v) solution (i.e., a 1:4 ratio of silk fibroin to 
lithium bromide). This was left in an oven at 60°C for 4 hours.
To remove the LiBr, the silk­LiBr solution was placed in a 3­kDa 
dialysis tube and was placed in a beaker containing ultrapure water. 
To ensure mixing, a large magnetic stir bar was used, and the beaker 
was placed on a magnetic stir plate. The water was changed a total 
of six times in 48 hours.
Last, the silk fibroin solution was removed from the dialysis tube 
and centrifuged at 9000 rpm at 4°C for 20 min to remove any impu­
rities. The centrifugation was repeated twice, and the final product 
was stored in Eppendorf tubes in a refrigerator at 4°C. To prevent 
gelation, all experiments were conducted within 2 weeks of extracting 
and purifying silk fibroin.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/6/eaay7952/DC1
Fig. S1. Optical micrographs of nanodroplet formation.
Fig. S2. Optical micrographs of nanodroplets following their formation.
Fig. S3. Characterization of nanoparticles using electron microscopy.
Fig. S4. Analysis of nanoparticle sizes and cellular control assays.
Movie S1. Nanodroplet generation at the junction.
Movie S2. 3D reconstruction of an ovarian cancer cell with protein-based nanoparticles 
rotating around the z axis.
View/request a protocol for this paper from Bio-protocol.
REFERENCES AND NOTES
 1. I. F. Guha, S. Anand, K. K. Varanasi, Creating nanoscale emulsions using condensation. 
Nat. Commun. 8, 1371 (2017).
 2. J. Bibette, F. L. Calderon, P. Poulin, Emulsions: Basic principles. Rep. Prog. Phys. 62, 
969–1033 (1999).
 3. X. Wang, E. Wenk, A. Matsumoto, L. Meinel, C. Li, D. L. Kaplan, Silk microspheres 
for encapsulation and controlled release. J. Control. Release 117, 360–370 (2007).
 4. D. M. Smith, J. K. Simon, J. R. Baker Jr., Applications of nanotechnology for immunology. 
Nat. Rev. Immunol. 13, 592–605 (2013).
 5. M. J. Lawrence, G. D. Rees, Microemulsion-based media as novel drug delivery systems. 
Adv. Drug Deliv. Rev. 45, 89–121 (2000).
 6. D. J. McClements, J. Rao, Food-grade nanoemulsions: Formulation, fabrication, 
properties, performance, biological fate, and potential toxicity. Crit. Rev. Food Sci. Nutr. 
51, 285–330 (2011).
 7. V. B. Patravale, S. D. Mandawgade, Novel cosmetic delivery systems: An application 
update. Int. J. Cosmet. Sci. 30, 19–33 (2008).
 8. U. Shimanovich, G. J. Bernardes, T. P. J. Knowles, A. Cavaco-Paulo, Protein micro- 
and nano-capsules for biomedical applications. Chem. Soc. Rev. 43, 1361–1371 (2014).
 9. S. L. Anna, N. Bontoux, H. A. Stone, Formation of dispersions using “flow focusing” 
in microchannels. Appl. Phys. Lett. 82, 364–366 (2003).
 10. R. K. Shah, H. C. Shum, A. C. Rowat, D. Lee, J. J. Agresti, A. S. Utada, L.-Y. Chu, J.-W. Kim, 
A. Fernandez-Nieves, C. J. Martinez, D. A. Weitz, Designer emulsions using microfluidics. 
Mater. Today 11, 18–27 (2008).
 11. Z. Toprakcioglu, P. K. Challa, A. Levin, T. P. J. Knowles, Observation of molecular 
self-assembly events in massively parallel microdroplet arrays. Lab Chip 18, 3303–3309 
(2018).
 12. N. R. Beer, E. K. Wheeler, L. Lee-Houghton, N. Watkins, S. Nasarabadi, N. Hebert, 
P. Leung, D. W. Arnold, C. G. Bailey, B. W. Colston, On-chip single-copy real-time 
reverse-transcription PCR in isolated picoliter droplets. Anal. Chem. 80, 1854–1858 
(2008).
 13. Y.-C. Tan, K. Hettiarachchi, M. Siu, Y.-R. Pan, A. P. Lee, Controlled microfluidic 
encapsulation of cells, proteins, and microbeads in lipid vesicles. J. Am. Chem. Soc. 128, 
5656–5658 (2006).
 14. M. Srisa-Art, A. J. DeMello, J. B. Edel, High-throughput DNA droplet assays using picoliter 
reactor volumes. Anal. Chem. 79, 6682–6689 (2007).
 15. X.-M. Zhou, U. Shimanovich, T. W. Herling, S. Wu, C. M. Dobson, T. P. J. Knowles, S. Perrett, 
Enzymatically active microgels from self-assembling protein nanofibrils for microflow 
chemistry. ACS Nano 9, 5772–5781 (2015).
 16. J.-u. Shim, G. Cristobal, D. R. Link, T. Thorsen, Y. Jia, K. Piattelli, S. Fraden, Control 
and measurement of the phase behavior of aqueous solutions using microfluidics.  
J. Am. Chem. Soc. 129, 8825–8835 (2007).
 17. X. Hou, Y. S. Zhang, G. T.-d. Santiago, M. M. Alvarez, J. Ribas, S. J. Jonas, P. S. Weiss, 
A. M. Andrews, J. Aizenberg, A. Khademhosseini, Interplay between materials 
and microfluidics. Nat. Rev. Mater. 2, 17016 (2017).
 18. D. Chen, E. Amstad, C.-X. Zhao, L. Cai, J. Fan, Q. Chen, M. Hai, S. Koehler, H. Zhang, 
F. Liang, Z. Yang, D. A. Weitz, Biocompatible amphiphilic hydrogel-solid dimer particles 
as colloidal surfactants. ACS Nano 11, 11978–11985 (2017).
 19. S.-H. Kim, J. W. Kim, D.-H. Kim, S.-H. Han, D. A. Weitz, Polymersomes containing a hydrogel 
network for high stability and controlled release. Small 9, 124–131 (2013).
 20. Z. Toprakcioglu, A. Levin, T. P. J. Knowles, Hierarchical biomolecular emulsions using 
3-D microfluidics with uniform surface chemistry. Biomacromolecules 18, 36423651 
(2017).
 21. U. Shimanovich, F. S. Ruggeri, E. De Genst, J. Adamcik, T. P. Barros, D. Porter, T. Müller, 
R. Mezzenga, C. M. Dobson, F. Vollrath, C. Holland, T. P. J. Knowles, Silk micrococoons 
for protein stabilisation and molecular encapsulation. Nat. Commun. 8, 15902  
(2017).
 22. X. Liu, Z. Toprakcioglu, A. J. Dear, A. Levin, F. S. Ruggeri, C. G. Taylor, M. Hu, J. R. Kumita, 
M. Andreasen, C. M. Dobson, U. Shimanovich, T. P. J. Knowles, Fabrication and 
characterization of reconstituted silk microgels for the storage and release of small 
molecules. Macromol. Rapid Commun. 40, 1800898 (2019).
 23. L. Zhang, Q. Feng, J. Wang, S. Zhang, B. Ding, Y. Wei, M. Dong, J.-Y. Ryu, T.-Y. Yoon, X. Shi, 
J. Sun, X. Jiang, Microfluidic synthesis of hybrid nanoparticles with controlled lipid layers: 
Understanding flexibility-regulated cell–nanoparticle interaction. ACS Nano 9, 
9912–9921 (2015).
 24. G. Niu, A. Ruditskiy, M. Vara, Y. Xia, Toward continuous and scalable production 
of colloidal nanocrystals by switching from batch to droplet reactors. Chem. Soc. Rev. 44, 
5806–5820 (2015).
 25. E. Amstad, M. Gopinadhan, C. Holtze, C. O. Osuji, M. P. Brenner, F. Spaepen, D. A. Weitz, 
Production of amorphous nanoparticles by supersonic spray-drying with a microfluidic 
nebulator. Science 349, 956–960 (2015).
 26. J. Ge, H. Lee, L. He, J. Kim, Z. Lu, H. Kim, J. Goebl, S. Kwon, Y. Yin, Magnetochromatic 
microspheres: Rotating photonic crystals. J. Am. Chem. Soc. 131, 15687–15694 
(2009).
 27. D. Dendukuri, P. S. Doyle, The synthesis and assembly of polymeric microparticles using 
microfluidics. Adv. Mater. 21, 4071–4086 (2009).
 28. D. N. Rockwood, R. C. Preda, T. Yücel, X. Wang, M. L. Lovett, D. L. Kaplan, Materials 
fabrication from Bombyx mori silk fibroin. Nat. Protoc. 6, 1612–1631 (2011).
 29. A. N. Mitropoulos, G. Perotto, S. Kim, B. Marelli, D. L. Kaplan, F. G. Omenetto, Synthesis of 
silk fibroin micro- and submicron spheres using a co-flow capillary device. Adv. Mater. 26, 
1105–1110 (2014).
 30. D. N. Breslauer, S. J. Muller, L. P. Lee, Generation of monodisperse silk microspheres 
prepared with microfluidics. Biomacromolecules 11, 643–647 (2010).
Toprakcioglu et al., Sci. Adv. 2020; 6 : eaay7952     7 February 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
8 of 8
 31. J. F. Zimmerman, R. Parameswaran, G. Murray, Y. Wang, M. Burke, B. Tian, Cellular 
uptake and dynamics of unlabeled freestanding silicon nanowires. Sci. Adv. 2, 1601039 
(2016).
 32. J. Kundu, Y. I. Chung, Y. H. Kim, G. Tae, S. C. Kundu, Silk fibroin nanoparticles for cellular 
uptake and control release. Int. J. Pharm. 388, 242–250 (2010).
 33. T.-G. Iversen, T. Skotland, K. Sandvig, Endocytosis and intracellular transport 
of nanoparticles: Present knowledge and need for future studies. Nano Today 6, 176–185 
(2011).
Acknowledgments 
Funding: The research leading to these results has received funding from the European 
Research Council (ERC) under the European Union’s Seventh Framework Programme 
(FP7/2007-2013) through the ERC grant PhysProt (agreement no. 337969), the BBSRC, the 
Frances and Augustus Newman Foundation, the Wellcome Trust, and the Cambridge Centre 
for Misfolding Diseases. The work was partially funded by the Horizon 2020 program through 
766972-FET-OPEN-NANOPHLOW. Author contributions: Z.T., P.K.C., and T.K. designed the 
study. Z.T., P.K.C., and D.B.M. performed the experiments. Z.T. analyzed the data. Z.T. and T.K. 
wrote the paper. All authors discussed the results and commented on the manuscript. 
Competing interests: The authors declare that they have no competing interests. Data and 
materials availability: All data needed to evaluate the conclusions in the paper are present in 
the paper and/or the Supplementary Materials. Additional data related to this paper may be 
requested from T.K. (tpjk2@cam.ac.uk).
Submitted 19 July 2019
Accepted 22 November 2019
Published 7 February 2020
10.1126/sciadv.aay7952
Citation: Z. Toprakcioglu, P. K. Challa, D. B. Morse, T. Knowles, Attoliter protein nanogels from 
droplet nanofluidics for intracellular delivery. Sci. Adv. 6, eaay7952 (2020).
